Mable Therapy secures £3.1 million Series A investment from Gresham House Ventures
Mable Therapy (Mable), the UK’s leading digital health platform for children’s speech and language therapy and counselling services, has secured a £3.1m Series A investment from Gresham House Ventures, a growth equity investor specialising in software and digitally driven businesses.
Mable addresses a significant and growing area of need – 1.4m children in the UK have long-term speech, language or communication needs and one in five children aged 5-16 have a diagnosed mental health problem.
Founded by Martha Currie and Elliot Agró in 2015, the business provides easy access to a nationwide network of therapists who deliver live, 1-2-1 sessions through a bespoke online platform that facilitates improved therapeutic outcomes in a child-friendly environment. Mable offers an affordable direct-to-consumer service, as well as solutions for the education and healthcare sectors, where technology adoption is now seen as vital to address the growing unmet demand. In the last year alone, Mable has delivered over 22,000 hours of therapy to over 3,000 children.
The deal, led by Benjamin Faulkner and Tom Makey, follows a series of recent investments by Gresham House Ventures in the healthcare and education sectors. The investment will enable Mable to expand its tech offering and bolster its sales and marketing function to accelerate adoption in the education sector.
As part of the investment, Gresham House Ventures has supported the appointment of Oli White as Mable’s CEO, bringing significant commercial expertise in the health and education technology sectors, most recently as chief commercial officer at Doc Abode. Education business leader, Andrea Carr, will also join Mable as independent Chair.
Mable Therapy was advised on the transaction by Zuleika Salter and James Balicki at finnCap Group.
Martha Currie, co-founder and clinical director at Mable Therapy, said:
“Mable’s mission has always been to design therapy that puts children at its core, giving them the best chance to reach their full potential. Our pioneering technology has already helped thousands of families across the UK, and with this investment by Gresham House Ventures we can take this support even further. We also look forward to welcoming to the team Oli and Andrea, whose expertise will be instrumental as we continue to enhance and expand our service beyond the UK.”
Elliot Agró, co-founder and head of product and technology at Mable Therapy, said:
“This investment by Gresham House Ventures will enable us to significantly expand Mable’s technology offering. It will support the development of an intra-therapy app designed to engage and empower children beyond session hours, as well as school screening tools to equip educators to effortlessly assess students’ mental health and speech and language needs. The fusion of technology and therapy offers huge potential to improve lives, and Mable is proud to be at the forefront of this transformative approach.”
Benjamin Faulkner, associate director at Gresham House Ventures, said:
“Mable’s technology transforms the lives of children in their crucial early stages of development. There is significant growth potential for Mable within the wider education and health sectors where its technology offering can drive meaningful efficiencies for public service providers. Martha and Elliot have built an excellent business that is backed by a wealth of clinical and technological expertise, and we are confident that Mable can continue to revolutionise the provision of this vital support across the UK.”
ENDS
Mable is a digital health platform that delivers speech & language therapy (SLT) and counselling services to children, focusing on ages 4-18. Mable uses gamification – games, activities and interactive resources – to provide improved therapeutic outcomes in a child-friendly environment. As a “telehealth” business, Mable utilises technology to deliver services remotely which would otherwise require a clinician to be physically present. Sessions are undertaken in real-time with two-way interaction between patient and qualified paediatric clinicians. Mable is a clinically led, outcomes-focused business that owns the clinical pathways for therapy delivery.
Mable was founded in 2015 by Martha Currie, clinical director, and Elliot Agró, chief technology officer. Currie is a qualified speech therapist and published telehealth expert, while Agró is an experienced software engineer. The founders have successfully grown the business by delivering high-quality and timely SLT and counselling sessions – serving 2,600 self-pay patients and 97 schools.
https://www.mabletherapy.com/about-us
About Gresham House Ventures and Gresham House
Gresham House Ventures is a growth equity investor specialised in scaling businesses with business models driven by technology, customer insight or service excellence. Gresham House Ventures aims to work with ambitious management teams who want the support of a flexible long-term investor who brings capital, insight and expertise. The team has been working together for over 10 years and has made over 100 investments into growth businesses. Gresham House Asset Management is the FCA authorised operating business of Gresham House plc, a London Stock Exchange-quoted specialist alternative asset manager. Gresham House is committed to operating responsibly and sustainably, taking the long view in delivering sustainable investment solutions.
